Human Microbiome - Global Market Outlook (2016-2022)

September 2016 | 168 pages | ID: H8D9CEDB88BEN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Human Microbiome Market is accounted for $130.23 million in 2015 and is expected to reach $521.23 million by 2022 growing at a CAGR of 21.9% during the forecast period. Increasing incidence of lifestyle diseases, growing geriatric population, and technological developments are some of the factors fueling the market growth. By product, Probiotics segment dominated the global market with largest share during the forecast period. North America and Europe commanded the market owing to the improved biotechnological and microbiological research infrastructure. However, Asia-Pacific is anticipated to grow at the highest CAGR owing to recuperating research infrastructure in the region.

Some of the key players in Human Microbiome market include Ritter Pharmaceuticals, Inc., E. I. du Pont de Nemours and Company, ViThera Pharmaceuticals, Metabiomics Corp., ActoGeniX, Optibiotix Health Plc, Vedanta Biosciences, Inc., MicroBiome Therapeutics, LLC, Second Genome, Inc., ENTEROME Bioscience, Yakult Honsha Co., Ltd., Osel, Inc., AvidBiotics, Rebiotix Inc., Merck & Co., Inc. and Seres Therapeutics.

Applications Covered:

• Diagnostics
• Therapeutics

Diseases Covered:

• Cancer
• Acute Diarrhea
• Diabetes
• Mental Disorders
• Autoimmune Disorders
• Obesity
• Other Diseases

Products Covered:

• Foods
• Drugs
• Probiotics
• Diagnostic Devices
• Prebiotics
• Medical Foods
• Nutritionally Incomplete Formulae
• Formulae for Metabolic Disorders
• Nutritionally Complete Formulae
• Oral Rehydration Products
• Other Probiotics Supplements

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Research Scenario
3.9 Emerging Markets
3.10 Supply Chain Analysis
3.11 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL HUMAN MICROBIOME MARKET, BY APPLICATION

5.1 Introduction
5.2 Diagnostics
5.3 Therapeutics

6 GLOBAL HUMAN MICROBIOME MARKET, BY DISEASE

6.1 Introduction
6.2 Cancer
6.3 Acute Diarrhea
6.4 Diabetes
6.5 Mental Disorders
6.6 Autoimmune Disorders
6.7 Obesity
6.8 Other Diseases

7 GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT

7.1 Introduction
7.2 Foods
7.3 Drugs
7.4 Probiotics
7.5 Diagnostic Devices
7.6 Prebiotics
7.7 Medical Foods
  7.7.1 Nutritionally Incomplete Formulae
  7.7.2 Formulae for Metabolic Disorders
  7.7.3 Nutritionally Complete Formulae
  7.7.4 Oral Rehydration Products
7.8 Other Probiotic Supplements

8 GLOBAL HUMAN MICROBIOME MARKET, BY GEOGRAPHY

8.1 North America
  8.1.1 US
  8.1.2 Canada
  8.1.3 Mexico
8.2 Europe
  8.2.1 Germany
  8.2.2 France
  8.2.3 Italy
  8.2.4 UK
  8.2.5 Spain
  8.2.6 Rest of Europe
8.3 Asia Pacific
  8.3.1 Japan
  8.3.2 China
  8.3.3 India
  8.3.4 Australia
  8.3.5 New Zealand
  8.3.6 Rest of Asia Pacific
8.4 Rest of the World
  8.4.1 Middle East
  8.4.2 Brazil
  8.4.3 Argentina
  8.4.4 South Africa
  8.4.5 Egypt

9 KEY DEVELOPMENTS

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 COMPANY PROFILING

10.1 Ritter Pharmaceuticals, Inc.
10.2 E. I. du Pont de Nemours and Company
10.3 ViThera Pharmaceuticals
10.4 Metabiomics Corp.
10.5 ActoGeniX
10.6 Optibiotix Health Plc
10.7 Vedanta Biosciences, Inc.
10.8 MicroBiome Therapeutics, LLC
10.9 Second Genome, Inc.
10.10 ENTEROME Bioscience
10.11 Yakult Honsha Co., Ltd.
10.12 Osel, Inc.
10.13 AvidBiotics
10.14 Rebiotix Inc.,
10.15 Merck & Co., Inc.
10.16 Seres Therapeutics

List Of Tables

LIST OF TABLES

1 Global Human Microbiome Market Outlook, By Region (2013-2022) ($MN)
2 Global Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
3 Global Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
4 Global Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
5 Global Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
6 Global Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
7 Global Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
8 Global Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
9 Global Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
10 Global Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
11 Global Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
12 Global Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
13 Global Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
14 Global Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
15 Global Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
16 Global Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
17 Global Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
18 Global Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
19 Global Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
20 Global Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
21 Global Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
22 Global Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
23 Global Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
24 Global Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
25 North America Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
26 North America Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
27 North America Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
28 North America Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
29 North America Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
30 North America Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
31 North America Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
32 North America Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
33 North America Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
34 North America Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
35 North America Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
36 North America Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
37 North America Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
38 North America Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
39 North America Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
40 North America Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
41 North America Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
42 North America Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
43 North America Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
44 North America Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
45 North America Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
46 North America Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
47 North America Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
48 North America Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
49 Europe Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
50 Europe Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
51 Europe Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
52 Europe Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
53 Europe Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
54 Europe Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
55 Europe Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
56 Europe Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
57 Europe Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
58 Europe Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
59 Europe Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
60 Europe Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
61 Europe Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
62 Europe Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
63 Europe Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
64 Europe Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
65 Europe Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
66 Europe Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
67 Europe Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
68 Europe Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
69 Europe Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
70 Europe Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
71 Europe Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
72 Europe Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
73 Asia Pacific Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
74 Asia Pacific Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
75 Asia Pacific Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
76 Asia Pacific Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
77 Asia Pacific Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
78 Asia Pacific Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
79 Asia Pacific Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
80 Asia Pacific Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
81 Asia Pacific Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
82 Asia Pacific Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
83 Asia Pacific Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
84 Asia Pacific Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
85 Asia Pacific Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
86 Asia Pacific Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
87 Asia Pacific Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
88 Asia Pacific Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
89 Asia Pacific Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
90 Asia Pacific Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
91 Asia Pacific Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
92 Asia Pacific Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
93 Asia Pacific Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
94 Asia Pacific Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
95 Asia Pacific Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
96 Asia Pacific Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
97 RoW Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
98 RoW Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
99 RoW Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
100 RoW Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
101 RoW Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
102 RoW Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
103 RoW Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
104 RoW Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
105 RoW Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
106 RoW Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
107 RoW Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
108 RoW Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
109 RoW Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
110 RoW Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
111 RoW Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
112 RoW Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
113 RoW Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
114 RoW Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
115 RoW Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
116 RoW Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
117 RoW Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
118 RoW Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
119 RoW Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
120 RoW Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)